Use of a Hypertension Tool to Manage Blood Pressure in Hemodialysis
Not Applicable
Completed
- Conditions
- Hypertension
- Registration Number
- NCT03089385
- Lead Sponsor
- University Health Network, Toronto
- Brief Summary
The objective of this project is to develop, validate, and implement a tool to help manager hypertension in patients on hemodialysis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
- ≥ 18 years of age
- Receiving in-centre HD for at least 3 months
- Considered hypertensive based on a median intradialytic blood pressure ≥ 140/90 mmgHG
Exclusion Criteria
- Are unable to provide informed consent
- Are deemed medically unstable by the primary physician
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Blood pressure 3 months
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does the hypertension tool target in hemodialysis-induced blood pressure dysregulation?
How does the hypertension tool compare to standard antihypertensive drug classes in hemodialysis patients' clinical outcomes?
Which biomarkers correlate with hypertension severity in hemodialysis patients using decision-support tools?
What adverse events are associated with hypertension management tools in hemodialysis and how are they mitigated?
Are there combination therapies involving the hypertension tool and renin-angiotensin system inhibitors for resistant hypertension in dialysis?
Trial Locations
- Locations (1)
Toronto General Hospital
🇨🇦Toronto, Ontario, Canada
Toronto General Hospital🇨🇦Toronto, Ontario, Canada